ConductScience.org, home

Paper348355

The pathogenesis of Graves' disease: an overview.

Volpé R. Clin Endocrinol Metab, 1978. Cited by 126 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The pathogenesis of Graves' disease: an overview. Papers, record 348355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/348355

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pathogenesis of Graves' disease: an overview.
PubMed
Journal
Clin Endocrinol Metab
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
126
iCite
Relative citation ratio, by iCite
4.88
iCite
Revised in PubMed
2019-10-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Volpé RR

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Graves DiseaseMajor topic
Autoantibodies
Cytotoxicity Tests, Immunologic
Humans
Immunity, Cellular
Long-Acting Thyroid Stimulator
Lymphocyte Activation
Lymphocytes
Macrophage Migration-Inhibitory Factors
Macrophages
Stress, Psychological
Thyroid Gland
Thyroid Hormones
Thyroiditis, Autoimmune

Source PubMed

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.

PMIDTitleJournalYearIn PapersSource
26,000,138Blocking type TSH receptor antibodies.Auto Immun Highlights2013https://conductscience.org/library/papers/26000138PubMed
14,693,778The relation of Graves' ophthalmopathy to circulating thyroid hormone status.Br J Ophthalmol2004https://conductscience.org/library/papers/14693778PubMed
9,972,676Chronic recurrent stress due to panic disorder does not precipitate Graves' disease.J Endocrinol Invest1998https://conductscience.org/library/papers/9972676PubMed
6,896,520Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease.J Endocrinol Invest1982https://conductscience.org/library/papers/6896520PubMed
6,893,055Painless thyroiditis followed by autoimmune disorders of the thyroid. A case report with biopsy.J Endocrinol Invest1980https://conductscience.org/library/papers/6893055PubMed
6,692,596Survival and tissue localization of xenogeneic human lymphocytes in hypothymic nude mice: observations in normal subjects and multiple sclerosis.Clin Exp Immunol1984https://conductscience.org/library/papers/6692596PubMed
6,424,781A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6424781PubMed
6,284,789
Thyroid-stimulating hormone (TSH) receptor antibodies and antibodies stimulating adenyl cyclase in relatives from two families with a high prevalence of Graves' hyperthyroidism: a ten-year follow-up study.
J Clin Immunol1982https://conductscience.org/library/papers/6284789PubMed
6,217,001Anti-thyroid drugs and lymphocyte function. II. The in vivo effect on blastogenesis and suppressor cell activity in Graves' disease.Clin Exp Immunol1982https://conductscience.org/library/papers/6217001PubMed
6,217,000Anti-thyroid drugs and lymphocyte function. I. The in vitro effect on blastogenesis and suppressor cell activity.Clin Exp Immunol1982https://conductscience.org/library/papers/6217000PubMed
6,172,233Clinical pharmacokinetics of antithyroid drugs.Clin Pharmacokinet1981https://conductscience.org/library/papers/6172233PubMed
3,838,096Antineutrophil autoantibodies in Graves' disease. Implications of thyrotropin binding to neutrophils.J Clin Invest1985https://conductscience.org/library/papers/3838096PubMed
3,754,571Palpebral asymmetry and hyperthyroidism. Two cases in connection with Graves' disease.J Neurol1986https://conductscience.org/library/papers/3754571PubMed
3,156,702Activated T cells in Graves' disease before treatment.Clin Exp Immunol1985https://conductscience.org/library/papers/3156702PubMed
2,974,088Mechanism and significance of abnormal blood level of beta 2-microglobulin in patients with Graves' disease.J Tongji Med Univ1988https://conductscience.org/library/papers/2974088PubMed
2,907,524Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.J Endocrinol Invest1988https://conductscience.org/library/papers/2907524PubMed
2,428,860Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.J Endocrinol Invest1986https://conductscience.org/library/papers/2428860PubMed
582,020Progress in endocrine exophthalmos.Br Med J1979https://conductscience.org/library/papers/582020PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/348355

GET https://conductscience.org/api/papers/v1/348355/authors